Search Results - "Thompson, Matthew D."
-
1
Role and Regulation of Pif1 Family Helicases at the Replication Fork
Published in International journal of molecular sciences (29-03-2022)“…Pif1 helicases are a multifunctional family of DNA helicases that are important for many aspects of genomic stability in the nucleus and mitochondria. Pif1…”
Get full text
Journal Article -
2
Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study
Published in Cancer epidemiology, biomarkers & prevention (01-06-2016)“…Lung cancer is a major health burden causing 160,000 and 1.6 million deaths annually in the United States and worldwide, respectively. While seeking to…”
Get full text
Journal Article -
3
Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Published in Clinical cancer research (01-09-2017)“…Adrenal incidentalomas must be differentiated from adrenocortical cancer (ACC). Currently, size, growth, and imaging characteristics determine the potential…”
Get full text
Journal Article -
4
Physiological effects of bean (Phaseolus vulgaris L.) consumption on cellular signaling in cancer
Published in Cell cycle (Georgetown, Tex.) (01-03-2012)“…Comment on: Thompson MD, et al. Carcinogenesis 2012; 33:226-32…”
Get full text
Journal Article -
5
Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models
Published in Cancer prevention research (Philadelphia, Pa.) (01-03-2015)“…Epidemiologic studies have shown that diabetics receiving the biguanide metformin, as compared with sulfonylureas or insulin, have a lower incidence of breast…”
Get full text
Journal Article -
6
A systems pharmacokinetic and pharmacodynamic approach to identify opportunities and pitfalls in energy stress-mediated chemoprevention: the use of metformin and other biguanides
Published in Current drug targets (01-12-2012)“…Metformin, a widely used anti-hyperglycemic drug in the biguanide class, is currently under investigation for the prevention of cancer. Surprisingly however,…”
Get more information
Journal Article -
7
Trends in the approval of cancer therapies by the FDA in the twenty-first century
Published in Nature reviews. Drug discovery (01-08-2023)“…The cancer treatment landscape has changed dramatically since the turn of the century, resulting in substantial improvements in outcomes for patients. This…”
Get full text
Journal Article -
8
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology
Published in Regulatory toxicology and pharmacology (01-05-2024)“…Pharmacokinetic (PK) models are increasingly submitted to the FDA to support first-in-human (FIH) dose selection of immune-oncology products. To examine…”
Get full text
Journal Article -
9
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy
Published in Epilepsy & behavior (01-10-2020)“…Cannabidiol (CBD) is a nonpsychoactive derivative of cannabis. Studies indicate that it is safe and effective in treating certain types of epilepsy. The…”
Get full text
Journal Article -
10
Monitoring helicase-catalyzed unwinding of multiple duplexes simultaneously
Published in Methods in enzymology (2022)“…Helicases catalyze the unwinding of duplex nucleic acids to aid a variety of cellular processes. Although helicases unwind duplex DNA in the same direction…”
Get more information
Journal Article -
11
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Published in Clinical cancer research (13-10-2023)“…On September 30, 2022, the FDA granted accelerated approval to futibatinib for the treatment of adult patients with previously treated, unresectable, locally…”
Get full text
Journal Article -
12
FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor
Published in Clinical cancer research (01-06-2023)“…On May 15, 2020, the FDA approved ripretinib for adult patients with advanced gastrointestinal stromal tumor who have received prior treatment with three or…”
Get full text
Journal Article -
13
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
Published in Clinical cancer research (01-08-2024)“…On November 8, 2023, the FDA approved fruquintinib, an inhibitor of vascular endothelial growth factor receptor (VEGFR)-1, -2, and -3, for the treatment of…”
Get full text
Journal Article -
14
A structural feature of Dda helicase which enhances displacement of streptavidin and trp repressor from DNA
Published in Protein science (01-02-2022)“…Helicases are molecular motors with many activities. They use the energy from ATP hydrolysis to unwind double‐stranded nucleic acids while translocating on the…”
Get full text
Journal Article -
15
A method for serial tissue processing and parallel analysis of aberrant crypt morphology, mucin depletion, and Beta-catenin staining in an experimental model of colon carcinogenesis
Published in Biological procedures online (18-05-2010)“…The use of architectural and morphological characteristics of cells for establishing prognostic indicators by which individual pathologies are assigned grade…”
Get full text
Journal Article -
16
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products
Published in Regulatory toxicology and pharmacology (01-02-2020)“…A systematic analysis of new commercial investigational new drug applications (IND) submitted to the FDA's Office of Hematology and Oncology Products (OHOP) in…”
Get full text
Journal Article -
17
Caregiver-reported religious beliefs and complementary and alternative medicine use among children admitted to an epilepsy monitoring unit
Published in Epilepsy & behavior (01-04-2017)“…Abstract Complementary and alternative medicine (CAM) includes a wide range of practices and products that are generally outside the use of conventional…”
Get full text
Journal Article -
18
Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat
Published in Cancer prevention research (Philadelphia, Pa.) (01-06-2015)“…Metformin is a widely prescribed drug for the treatment of type II diabetes. Although epidemiologic data have provided a strong rationale for investigating the…”
Get full text
Journal Article -
19
Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment
Published in Journal of pharmaceutical sciences (01-01-2012)“…A well-stirred tank (WST) has been the predominant flow-limited tissue compartment model in physiologically based pharmacokinetic (PBPK) modeling. Recently, we…”
Get more information
Journal Article -
20
Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limited and flow-limited transport
Published in Journal of pharmacokinetics and pharmacodynamics (01-08-2011)“…Although the implementation of a flow-limited, well-stirred tank (WST) single-compartment tissue model in pharmacokinetics and toxicokinetics is widespread,…”
Get full text
Journal Article